Stock RLF RELIEF THERAPEUTICS HOLDING SA
Add to a list
To use this feature you must be a member
Log inSign up

Financials Relief Therapeutics Holding SA

Equities

RLF

CH1251125998

Biotechnology & Medical Research

End-of-day quote Swiss Exchange
Other stock markets
 18:00:00 2024-04-24 EDT 		5-day change 1st Jan Change
1.25 CHF -6.72% Intraday chart for Relief Therapeutics Holding SA -4.58% -37.19%
03-22 Sector Update: Health Care Stocks Steady Pre-Bell Friday MT
03-22 Sector Update: Health Care MT

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 20.24 10.86 2.114 873.4 274.3 132
Enterprise Value (EV) 1 21.12 11.65 3.724 836 233.8 117.1
P/E ratio -6.89 x -24.5 x -0.28 x -82.9 x -6.44 x -2.5 x
Yield - - - - - -
Capitalization / Revenue - 19,225,462 x - - 82,606,200 x 21,700,294 x
EV / Revenue - 20,620,152 x - - 70,411,981 x 19,251,190 x
EV / EBITDA -12.2 x -24.1 x -3.94 x -43.2 x -7.22 x -3.69 x
EV / FCF -33.9 x -21.8 x -6.83 x -56.2 x -10.9 x -6.11 x
FCF Yield -2.95% -4.59% -14.7% -1.78% -9.15% -16.4%
Price to Book 0.96 x 0.51 x 0.15 x 13 x 1.41 x 0.91 x
Nbr of stocks (in thousands) 5,060 5,222 5,285 8,117 11,026 10,997
Reference price 2 4.000 2.080 0.4000 107.6 24.88 12.00
Announcement Date 18-04-30 19-04-30 20-04-30 21-04-15 22-04-01 23-04-14
1CHF in Million2CHF
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales - 0.565 - - 3.321 6.081
EBITDA 1 -1.733 -0.483 -0.946 -19.36 -32.38 -31.74
EBIT 1 -1.736 -0.5 -0.947 -19.36 -34.24 -35.21
Operating Margin - -88.5% - - -1,030.89% -578.98%
Earnings before Tax (EBT) 1 -1.901 -0.416 -12.16 -6.261 -35.52 -54.32
Net income 1 -2.887 -0.436 -7.46 -7.828 -34.7 -50.79
Net margin - -77.17% - - -1,045.02% -835.22%
EPS 2 -0.5809 -0.0851 -1.418 -1.298 -3.864 -4.805
Free Cash Flow 1 -0.623 -0.535 -0.5456 -14.87 -21.39 -19.15
FCF margin - -94.69% - - -644.23% -314.94%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 18-04-30 19-04-30 20-04-30 21-04-15 22-04-01 23-04-14
1CHF in Million2CHF
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 0.88 0.79 1.61 - - -
Net Cash position 1 - - - 37.4 40.5 14.9
Leverage (Debt/EBITDA) -0.5061 x -1.631 x -1.702 x - - -
Free Cash Flow 1 -0.62 -0.54 -0.55 -14.9 -21.4 -19.2
ROE (net income / shareholders' equity) -13.4% -2.06% -41.9% -19.2% -27.9% -31.1%
ROA (Net income/ Total Assets) -3.48% -0.94% -2.14% -24.7% -13% -9.99%
Assets 1 83.01 46.43 349.4 31.67 267.3 508.3
Book Value Per Share 2 4.180 4.080 2.710 8.260 17.70 13.20
Cash Flow per Share 2 0.0300 0.0500 0.0200 4.690 4.350 1.750
Capex - - - - - 0.03
Capex / Sales - - - - - 0.54%
Announcement Date 18-04-30 19-04-30 20-04-30 21-04-15 22-04-01 23-04-14
1CHF in Million2CHF
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Chiffre d''affaires - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
RELIEF THERAPEUTICS HOLDING SA Stock Relief Therapeutics Holding SA
-37.19% 17.82M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. RLF Stock
  4. Financials Relief Therapeutics Holding SA